CLDX - Celldex Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts5555
Avg. Estimate-0.2-0.21-0.73-0.74
Low Estimate-0.27-0.27-0.96-1.07
High Estimate-0.11-0.14-0.55-0.17
Year Ago EPS-0.28-0.23-0.72-0.73
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts5555
Avg. Estimate2.31M2.63M19.67M43.83M
Low Estimate1.46M1.5M6.5M5M
High Estimate3.08M4.07M56M183.18M
Year Ago Sales1.53M3.83M12.74M19.67M
Sales Growth (year/est)50.60%-31.30%54.40%122.80%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.29-0.27-0.27-0.25
EPS Actual-0.28-0.23-0.2-0.03
Difference0.010.040.070.22
Surprise %3.40%14.80%25.90%88.00%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.2-0.21-0.73-0.74
7 Days Ago-0.2-0.21-0.73-0.74
30 Days Ago-0.19-0.19-0.84-0.75
60 Days Ago-0.22-0.23-0.9-0.77
90 Days Ago-0.22-0.23-0.9-0.77
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days113N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCLDXIndustrySectorS&P 500
Current Qtr.28.60%N/AN/A0.42
Next Qtr.8.70%N/AN/A0.38
Current Year-1.40%N/AN/A0.20
Next Year-1.40%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A